Silver Book Fact

Longitudinal study on vision loss in Medicare patients

A longitudinal study that followed Medicare patients found that after 9 years, almost 50% of survivors had developed glaucoma, cataract, or macular degeneration.

Lee, Paul P., Zachary W. Feldman, Jan Ostermann, Derek S. Brown, and Frank A. Sloan. Longitudinal Prevalence of Major Eye Diseases. Archives of Ophthalmology. 2003; 121(9): 1303-10. http://archopht.ama-assn.org/cgi/content/abstract/121/9/1303?etoc

Reference

Title
Longitudinal Prevalence of Major Eye Diseases
Publication
Archives of Ophthalmology
Publication Date
2003
Authors
Lee, Paul P., Zachary W. Feldman, Jan Ostermann, Derek S. Brown, and Frank A. Sloan
Volume & Issue
Volume 121, Issue 9
Pages
1303-10
URL
Read Full Resource

Categories

  • Cost of Disease
  • Age - A Major Risk Factor
  • Human Burden

Related Facts

  • The annual direct medical costs (including outpatient, inpatient, and prescription drug services) for Americans age 40 and older with age-related macular degeneration (AMD) is $575 million.  
  • An estimated 1,288,275 Americans age 40 and older are blind.  
  • In 2001, approximately 2.9 million glaucoma patients visited physicians or hospitals for treatment of their disease.  
  • The total annual loss for the 3.7 million people in the U.S. who are visually impaired or blind is estimated at more than 209,000 quality-adjusted life-years.  
  • The average cost in 2004 per glaucoma patient age 40 to 64 using inpatient services was $2,270. The average cost per patient 65 years and older was $4,929.